Fresenius SE & Co. KGaA (FSNUF)

Market Cap	30.40B
Revenue (ttm)	26.33B
Net Income (ttm)	1.34B
Shares Out	n/a
EPS (ttm)	2.38
PE Ratio	22.67
Forward PE	12.79
Dividend	1.13 (1.94%)
Ex-Dividend Date	May 23, 2025

Volume	100
Average Volume	2,058
Open	58.16
Previous Close	55.23
Day's Range	58.16 - 58.16
52-Week Range	32.16 - 58.16
Beta	0.92
RSI	67.21
Earnings Date	Nov 5, 2025

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1912
• Employees: 176,486
• Stock Exchange: OTCMKTS
• Ticker Symbol: FSNUF

Financial Performance

Financial numbers in EUR